Attrax Putty
-
Spine
NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty
Attrax Putty is now on-label for use with cervical Modulus interbody implants SAN DIEGO, Feb. 21, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the…
Read More » -
Biologics
NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company’s Thoracolumbar Interbody Portfolio
Attrax Putty is the first and only synthetic biologic to receive 510(k) clearance for use with thoracolumbar interbody systems SAN…
Read More » -
Biologics
Randomized Controlled Trial Results Published in ‘Spine’ Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion
– Attrax Putty is now the first and only ceramic bone graft substitute supported by Level I evidence to demonstrate…
Read More »